

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.05026844 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.33815381 |
| 3 | negative regulation of cell killing (GO:0031342) | 4.76973963 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.76973963 |
| 5 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.63715017 |
| 6 | neural tube formation (GO:0001841) | 4.24455031 |
| 7 | negative T cell selection (GO:0043383) | 4.04945697 |
| 8 | negative thymic T cell selection (GO:0045060) | 3.89978440 |
| 9 | neutrophil mediated immunity (GO:0002446) | 3.86363182 |
| 10 | detection of molecule of bacterial origin (GO:0032490) | 3.86121081 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.85275100 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.85275100 |
| 13 | definitive hemopoiesis (GO:0060216) | 3.83662832 |
| 14 | histone H3-K4 trimethylation (GO:0080182) | 3.81865845 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 3.77596470 |
| 16 | interkinetic nuclear migration (GO:0022027) | 3.76001175 |
| 17 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.70482954 |
| 18 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.69919174 |
| 19 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.68892061 |
| 20 | cellular response to ethanol (GO:0071361) | 3.66121882 |
| 21 | positive T cell selection (GO:0043368) | 3.65982357 |
| 22 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.63791288 |
| 23 | protein targeting to Golgi (GO:0000042) | 3.58738806 |
| 24 | positive thymic T cell selection (GO:0045059) | 3.56910874 |
| 25 | establishment of protein localization to Golgi (GO:0072600) | 3.51031238 |
| 26 | microglial cell activation (GO:0001774) | 3.50554611 |
| 27 | dosage compensation (GO:0007549) | 3.49089274 |
| 28 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.48828498 |
| 29 | myeloid leukocyte mediated immunity (GO:0002444) | 3.48744976 |
| 30 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.38381455 |
| 31 | negative regulation of neurotransmitter transport (GO:0051589) | 3.36254297 |
| 32 | cellular extravasation (GO:0045123) | 3.35137335 |
| 33 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.34791014 |
| 34 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.34021278 |
| 35 | nerve growth factor signaling pathway (GO:0038180) | 3.32235039 |
| 36 | macrophage activation (GO:0042116) | 3.30195981 |
| 37 | leukocyte aggregation (GO:0070486) | 3.29442300 |
| 38 | T cell selection (GO:0045058) | 3.28810983 |
| 39 | peptidyl-lysine trimethylation (GO:0018023) | 3.28554175 |
| 40 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.23032407 |
| 41 | regulation of pigment cell differentiation (GO:0050932) | 3.20081945 |
| 42 | thymic T cell selection (GO:0045061) | 3.14632183 |
| 43 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.12679935 |
| 44 | response to interleukin-15 (GO:0070672) | 3.10329905 |
| 45 | interferon-gamma production (GO:0032609) | 3.07679928 |
| 46 | histone mRNA catabolic process (GO:0071044) | 2.99328406 |
| 47 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.95609777 |
| 48 | hepatocyte apoptotic process (GO:0097284) | 2.92774117 |
| 49 | lymph vessel development (GO:0001945) | 2.91729231 |
| 50 | histone H3-K36 demethylation (GO:0070544) | 2.89799437 |
| 51 | protein K48-linked deubiquitination (GO:0071108) | 2.86337622 |
| 52 | macrophage activation involved in immune response (GO:0002281) | 2.85774965 |
| 53 | positive regulation of developmental pigmentation (GO:0048087) | 2.84921686 |
| 54 | activated T cell proliferation (GO:0050798) | 2.83996171 |
| 55 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.82624371 |
| 56 | positive regulation of mast cell activation (GO:0033005) | 2.81788772 |
| 57 | negative regulation of T cell mediated immunity (GO:0002710) | 2.81714928 |
| 58 | natural killer cell activation involved in immune response (GO:0002323) | 2.79164787 |
| 59 | cellular response to interleukin-15 (GO:0071350) | 2.79049842 |
| 60 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.79036928 |
| 61 | protein K63-linked deubiquitination (GO:0070536) | 2.78733525 |
| 62 | megakaryocyte development (GO:0035855) | 2.73950759 |
| 63 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.71731822 |
| 64 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.71731822 |
| 65 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.68895237 |
| 66 | regulation of necroptotic process (GO:0060544) | 2.66970714 |
| 67 | regulation of regulatory T cell differentiation (GO:0045589) | 2.66881674 |
| 68 | detection of bacterium (GO:0016045) | 2.66643424 |
| 69 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.65696195 |
| 70 | nucleus localization (GO:0051647) | 2.65061525 |
| 71 | protein K11-linked deubiquitination (GO:0035871) | 2.63107515 |
| 72 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.61989399 |
| 73 | T-helper cell differentiation (GO:0042093) | 2.61989399 |
| 74 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.61566363 |
| 75 | regulation of B cell differentiation (GO:0045577) | 2.59977566 |
| 76 | positive regulation of granulocyte differentiation (GO:0030854) | 2.59801449 |
| 77 | embryonic process involved in female pregnancy (GO:0060136) | 2.59477432 |
| 78 | centriole replication (GO:0007099) | 2.55391719 |
| 79 | T cell costimulation (GO:0031295) | 2.55211061 |
| 80 | ER overload response (GO:0006983) | 2.54995203 |
| 81 | cellular response to zinc ion (GO:0071294) | 2.54705713 |
| 82 | regulation of establishment of cell polarity (GO:2000114) | 2.54457226 |
| 83 | embryonic hemopoiesis (GO:0035162) | 2.54387939 |
| 84 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.54218596 |
| 85 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.52057971 |
| 86 | lymphocyte costimulation (GO:0031294) | 2.51421890 |
| 87 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.51130512 |
| 88 | Golgi to endosome transport (GO:0006895) | 2.50735706 |
| 89 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.50393900 |
| 90 | T cell receptor signaling pathway (GO:0050852) | 2.50280291 |
| 91 | detection of other organism (GO:0098543) | 2.50105028 |
| 92 | T cell homeostasis (GO:0043029) | 2.49925499 |
| 93 | protein localization to Golgi apparatus (GO:0034067) | 2.49789760 |
| 94 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.49386269 |
| 95 | alpha-beta T cell differentiation (GO:0046632) | 2.47511543 |
| 96 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.46793127 |
| 97 | B cell receptor signaling pathway (GO:0050853) | 2.44787640 |
| 98 | positive regulation of histone deacetylation (GO:0031065) | 2.44041716 |
| 99 | T cell migration (GO:0072678) | 2.44004900 |
| 100 | negative regulation of interleukin-17 production (GO:0032700) | 2.42669224 |
| 101 | positive regulation of mast cell degranulation (GO:0043306) | 2.42173798 |
| 102 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.42173798 |
| 103 | signal peptide processing (GO:0006465) | 2.40341027 |
| 104 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.39607283 |
| 105 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.38714750 |
| 106 | negative regulation of bone resorption (GO:0045779) | 2.38697858 |
| 107 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.37628804 |
| 108 | T cell differentiation (GO:0030217) | 2.36610632 |
| 109 | positive regulation of interleukin-2 production (GO:0032743) | 2.34329578 |
| 110 | detection of external biotic stimulus (GO:0098581) | 2.33628000 |
| 111 | negative regulation of bone remodeling (GO:0046851) | 2.33497513 |
| 112 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.32823384 |
| 113 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.32823384 |
| 114 | modulation by symbiont of host immune response (GO:0052553) | 2.32823384 |
| 115 | positive regulation by symbiont of host defense response (GO:0052509) | 2.32823384 |
| 116 | modulation by symbiont of host defense response (GO:0052031) | 2.32823384 |
| 117 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.32823384 |
| 118 | central nervous system neuron axonogenesis (GO:0021955) | 2.32816925 |
| 119 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.32660687 |
| 120 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.32565274 |
| 121 | alpha-beta T cell activation (GO:0046631) | 2.32071234 |
| 122 | early endosome to late endosome transport (GO:0045022) | 2.31912645 |
| 123 | neutrophil activation (GO:0042119) | 2.30660489 |
| 124 | negative regulation of osteoblast proliferation (GO:0033689) | 2.30579754 |
| 125 | peptidyl-lysine methylation (GO:0018022) | 2.30569367 |
| 126 | lymphocyte homeostasis (GO:0002260) | 2.30553259 |
| 127 | regulation of T cell tolerance induction (GO:0002664) | 2.30181315 |
| 128 | heterotypic cell-cell adhesion (GO:0034113) | 2.29811311 |
| 129 | centrosome localization (GO:0051642) | 2.29544906 |
| 130 | germ cell migration (GO:0008354) | 2.29474676 |
| 131 | snRNA transcription (GO:0009301) | 2.29232874 |
| 132 | venous blood vessel morphogenesis (GO:0048845) | 2.29149703 |
| 133 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.29062944 |
| 134 | microtubule anchoring (GO:0034453) | 2.28891682 |
| 135 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.28818445 |
| 136 | neutrophil activation involved in immune response (GO:0002283) | 2.28161792 |
| 137 | cellular response to epinephrine stimulus (GO:0071872) | 2.27962042 |
| 138 | negative regulation of adaptive immune response (GO:0002820) | 2.27954625 |
| 139 | B cell homeostasis (GO:0001782) | 2.27880105 |
| 140 | positive regulation of B cell differentiation (GO:0045579) | 2.27710785 |
| 141 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.27444164 |
| 142 | histone H3-K9 modification (GO:0061647) | 2.27298897 |
| 143 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.27138730 |
| 144 | response to epinephrine (GO:0071871) | 2.26706118 |
| 145 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.25398608 |
| 146 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.25398608 |
| 147 | T cell differentiation involved in immune response (GO:0002292) | 2.25398608 |
| 148 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.25392467 |
| 149 | monocyte differentiation (GO:0030224) | 2.24402899 |
| 150 | mast cell activation (GO:0045576) | 2.23790335 |
| 151 | natural killer cell differentiation (GO:0001779) | 2.23630730 |
| 152 | histone H3-K9 methylation (GO:0051567) | 2.23043355 |
| 153 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.21929574 |
| 154 | response to host immune response (GO:0052572) | 2.21726748 |
| 155 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.21726748 |
| 156 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.21249921 |
| 157 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.20745167 |
| 158 | regulation of respiratory system process (GO:0044065) | 2.20336072 |
| 159 | negative regulation of B cell proliferation (GO:0030889) | 2.20317669 |
| 160 | nuclear pore complex assembly (GO:0051292) | 2.20069380 |
| 161 | regulation of sarcomere organization (GO:0060297) | 2.19893037 |
| 162 | JAK-STAT cascade (GO:0007259) | 2.19594925 |
| 163 | response to type I interferon (GO:0034340) | 2.19072072 |
| 164 | regulation of DNA endoreduplication (GO:0032875) | 2.19052052 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.39712848 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.30663229 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.84312258 |
| 4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.83055657 |
| 5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.65803932 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.62146133 |
| 7 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.43925941 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.41260289 |
| 9 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.29817275 |
| 10 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.22017399 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.20968008 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.16032426 |
| 13 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.15131955 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.14902916 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.98725726 |
| 16 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.91183651 |
| 17 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.89715417 |
| 18 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.79823978 |
| 19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.78749509 |
| 20 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.74508156 |
| 21 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.69905317 |
| 22 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.65146583 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.64159211 |
| 24 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.61687595 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.61488742 |
| 26 | TP53_16413492_ChIP-PET_HCT116_Human | 1.61127363 |
| 27 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59206976 |
| 28 | * GBX2_23144817_ChIP-Seq_PC3_Human | 1.59082230 |
| 29 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.58202714 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 1.57459142 |
| 31 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.53013601 |
| 32 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.48406044 |
| 33 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.46914602 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45792642 |
| 35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.43518647 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.43290149 |
| 37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.42990000 |
| 38 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.42970073 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.39890760 |
| 40 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.37351109 |
| 41 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.37351109 |
| 42 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.36979414 |
| 43 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.36730616 |
| 44 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.36545777 |
| 45 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.35900220 |
| 46 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35867003 |
| 47 | MYB_26560356_Chip-Seq_TH1_Human | 1.35613818 |
| 48 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.35346488 |
| 49 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.34514854 |
| 50 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.33730604 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.31851155 |
| 52 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.31235997 |
| 53 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30122022 |
| 54 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.27366142 |
| 55 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.27338810 |
| 56 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.27220892 |
| 57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.25303064 |
| 58 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.24515562 |
| 59 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24331353 |
| 60 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.24297320 |
| 61 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24245033 |
| 62 | P300_19829295_ChIP-Seq_ESCs_Human | 1.23968841 |
| 63 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.22126856 |
| 64 | VDR_22108803_ChIP-Seq_LS180_Human | 1.22057632 |
| 65 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.21144893 |
| 66 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.21095948 |
| 67 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.20362850 |
| 68 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20238074 |
| 69 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19571681 |
| 70 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.19383056 |
| 71 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.18703178 |
| 72 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.18413766 |
| 73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17875537 |
| 74 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.16927076 |
| 75 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.16741927 |
| 76 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.16714624 |
| 77 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.16576500 |
| 78 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.16313262 |
| 79 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.15344709 |
| 80 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.14844271 |
| 81 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.14403037 |
| 82 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.12657581 |
| 83 | RXR_22108803_ChIP-Seq_LS180_Human | 1.10885363 |
| 84 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.10872892 |
| 85 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.08120218 |
| 86 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07557090 |
| 87 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.06839740 |
| 88 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.06547992 |
| 89 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.06265864 |
| 90 | CJUN_26792858_Chip-Seq_BT549_Human | 1.05422024 |
| 91 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.05111379 |
| 92 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.04346496 |
| 93 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.04141024 |
| 94 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.03443940 |
| 95 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.02999360 |
| 96 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.02849719 |
| 97 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.02417984 |
| 98 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.01839287 |
| 99 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.01732971 |
| 100 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.01554954 |
| 101 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.00884523 |
| 102 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.00383073 |
| 103 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00322611 |
| 104 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00322611 |
| 105 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.00186208 |
| 106 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00002807 |
| 107 | TCF4_23295773_ChIP-Seq_U87_Human | 0.99500468 |
| 108 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.98685581 |
| 109 | FUS_26573619_Chip-Seq_HEK293_Human | 0.98675415 |
| 110 | EWS_26573619_Chip-Seq_HEK293_Human | 0.98508563 |
| 111 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.98349773 |
| 112 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.98300231 |
| 113 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96370242 |
| 114 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.96167635 |
| 115 | MAF_26560356_Chip-Seq_TH1_Human | 0.96054091 |
| 116 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.95949193 |
| 117 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.95356898 |
| 118 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.95177520 |
| 119 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93909633 |
| 120 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92833229 |
| 121 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.92660726 |
| 122 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.92587254 |
| 123 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.92303525 |
| 124 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92174874 |
| 125 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92174874 |
| 126 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91378271 |
| 127 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90678879 |
| 128 | AR_25329375_ChIP-Seq_VCAP_Human | 0.89760829 |
| 129 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.89759682 |
| 130 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89164329 |
| 131 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.88576222 |
| 132 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.88419469 |
| 133 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.88170023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 4.27207374 |
| 2 | MP0000569_abnormal_digit_pigmentation | 3.42032389 |
| 3 | MP0002166_altered_tumor_susceptibility | 3.31847839 |
| 4 | MP0003300_gastrointestinal_ulcer | 3.03220289 |
| 5 | MP0002009_preneoplasia | 3.02217349 |
| 6 | MP0003828_pulmonary_edema | 3.01054631 |
| 7 | MP0005671_abnormal_response_to | 2.89645351 |
| 8 | MP0003763_abnormal_thymus_physiology | 2.83069061 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.65681462 |
| 10 | MP0000427_abnormal_hair_cycle | 2.64952641 |
| 11 | MP0001879_abnormal_lymphatic_vessel | 2.43495934 |
| 12 | MP0002877_abnormal_melanocyte_morpholog | 2.33609662 |
| 13 | MP0002006_tumorigenesis | 2.26997566 |
| 14 | MP0003303_peritoneal_inflammation | 2.22399110 |
| 15 | MP0001790_abnormal_immune_system | 2.22228696 |
| 16 | MP0005387_immune_system_phenotype | 2.22228696 |
| 17 | MP0004130_abnormal_muscle_cell | 2.10336316 |
| 18 | MP0004883_abnormal_blood_vessel | 2.06511358 |
| 19 | MP0009278_abnormal_bone_marrow | 2.05209010 |
| 20 | MP0002396_abnormal_hematopoietic_system | 2.01124231 |
| 21 | MP0010386_abnormal_urinary_bladder | 2.00749071 |
| 22 | MP0000685_abnormal_immune_system | 1.91122161 |
| 23 | MP0005423_abnormal_somatic_nervous | 1.89434502 |
| 24 | MP0005171_absent_coat_pigmentation | 1.88707439 |
| 25 | MP0001800_abnormal_humoral_immune | 1.88682339 |
| 26 | MP0002420_abnormal_adaptive_immunity | 1.86882443 |
| 27 | MP0004808_abnormal_hematopoietic_stem | 1.86290339 |
| 28 | MP0005409_darkened_coat_color | 1.86101924 |
| 29 | MP0003787_abnormal_imprinting | 1.85646238 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.84974360 |
| 31 | MP0000015_abnormal_ear_pigmentation | 1.83208869 |
| 32 | MP0001819_abnormal_immune_cell | 1.81979802 |
| 33 | MP0004510_myositis | 1.77764168 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.76913828 |
| 35 | MP0008877_abnormal_DNA_methylation | 1.75920164 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.75741811 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.73943313 |
| 38 | MP0002723_abnormal_immune_serum | 1.70575725 |
| 39 | MP0002419_abnormal_innate_immunity | 1.70428863 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.67714511 |
| 41 | MP0002398_abnormal_bone_marrow | 1.66210336 |
| 42 | MP0004084_abnormal_cardiac_muscle | 1.65246996 |
| 43 | MP0009785_altered_susceptibility_to | 1.65188800 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.64610018 |
| 45 | MP0010368_abnormal_lymphatic_system | 1.63879864 |
| 46 | MP0002693_abnormal_pancreas_physiology | 1.56520725 |
| 47 | MP0002928_abnormal_bile_duct | 1.56424072 |
| 48 | MP0003045_fibrosis | 1.55869425 |
| 49 | MP0008260_abnormal_autophagy | 1.52818834 |
| 50 | MP0003890_abnormal_embryonic-extraembry | 1.52798911 |
| 51 | MP0001873_stomach_inflammation | 1.51577458 |
| 52 | MP0008004_abnormal_stomach_pH | 1.50814013 |
| 53 | MP0005174_abnormal_tail_pigmentation | 1.47112318 |
| 54 | MP0003221_abnormal_cardiomyocyte_apopto | 1.45741170 |
| 55 | MP0000716_abnormal_immune_system | 1.45150406 |
| 56 | MP0005025_abnormal_response_to | 1.44075819 |
| 57 | MP0005408_hypopigmentation | 1.43378880 |
| 58 | MP0003724_increased_susceptibility_to | 1.43185508 |
| 59 | MP0002998_abnormal_bone_remodeling | 1.39500298 |
| 60 | MP0002095_abnormal_skin_pigmentation | 1.36758446 |
| 61 | MP0003436_decreased_susceptibility_to | 1.34033346 |
| 62 | MP0000703_abnormal_thymus_morphology | 1.33931444 |
| 63 | MP0003943_abnormal_hepatobiliary_system | 1.30692489 |
| 64 | MP0005164_abnormal_response_to | 1.29023160 |
| 65 | MP0010155_abnormal_intestine_physiology | 1.28270779 |
| 66 | MP0004142_abnormal_muscle_tone | 1.26069610 |
| 67 | MP0000371_diluted_coat_color | 1.21664704 |
| 68 | MP0005464_abnormal_platelet_physiology | 1.19871335 |
| 69 | MP0003252_abnormal_bile_duct | 1.19778220 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 1.18323379 |
| 71 | MP0001545_abnormal_hematopoietic_system | 1.18323379 |
| 72 | MP0001944_abnormal_pancreas_morphology | 1.17237575 |
| 73 | MP0005075_abnormal_melanosome_morpholog | 1.17199607 |
| 74 | MP0004381_abnormal_hair_follicle | 1.15064327 |
| 75 | MP0002332_abnormal_exercise_endurance | 1.14229724 |
| 76 | MP0005187_abnormal_penis_morphology | 1.13434276 |
| 77 | MP0002405_respiratory_system_inflammati | 1.13192899 |
| 78 | MP0003866_abnormal_defecation | 1.12249382 |
| 79 | MP0002148_abnormal_hypersensitivity_rea | 1.12189547 |
| 80 | MP0002722_abnormal_immune_system | 1.08289154 |
| 81 | MP0003121_genomic_imprinting | 1.08225067 |
| 82 | MP0000689_abnormal_spleen_morphology | 1.05907969 |
| 83 | MP0004134_abnormal_chest_morphology | 1.03989546 |
| 84 | MP0006054_spinal_hemorrhage | 1.03487994 |
| 85 | MP0002429_abnormal_blood_cell | 1.03344226 |
| 86 | MP0004947_skin_inflammation | 1.02409286 |
| 87 | MP0001845_abnormal_inflammatory_respons | 0.99162540 |
| 88 | MP0010678_abnormal_skin_adnexa | 0.97180881 |
| 89 | MP0001188_hyperpigmentation | 0.96889649 |
| 90 | MP0003868_abnormal_feces_composition | 0.96450835 |
| 91 | MP0000858_altered_metastatic_potential | 0.96188206 |
| 92 | MP0002102_abnormal_ear_morphology | 0.96160488 |
| 93 | MP0001186_pigmentation_phenotype | 0.94373481 |
| 94 | MP0004036_abnormal_muscle_relaxation | 0.93629224 |
| 95 | MP0002933_joint_inflammation | 0.92305952 |
| 96 | MP0001851_eye_inflammation | 0.91033365 |
| 97 | MP0002075_abnormal_coat/hair_pigmentati | 0.90818653 |
| 98 | MP0005248_abnormal_Harderian_gland | 0.90066476 |
| 99 | MP0001853_heart_inflammation | 0.88936789 |
| 100 | MP0004215_abnormal_myocardial_fiber | 0.85540389 |
| 101 | MP0005220_abnormal_exocrine_pancreas | 0.85217298 |
| 102 | MP0000778_abnormal_nervous_system | 0.85179364 |
| 103 | MP0000383_abnormal_hair_follicle | 0.84705615 |
| 104 | MP0002177_abnormal_outer_ear | 0.84293445 |
| 105 | MP0002127_abnormal_cardiovascular_syste | 0.81834017 |
| 106 | MP0003795_abnormal_bone_structure | 0.80982466 |
| 107 | MP0003632_abnormal_nervous_system | 0.80128892 |
| 108 | MP0002168_other_aberrant_phenotype | 0.80097699 |
| 109 | MP0003091_abnormal_cell_migration | 0.78004474 |
| 110 | MP0001958_emphysema | 0.77707860 |
| 111 | MP0004147_increased_porphyrin_level | 0.77231600 |
| 112 | MP0002234_abnormal_pharynx_morphology | 0.76352677 |
| 113 | MP0002909_abnormal_adrenal_gland | 0.75450093 |
| 114 | MP0002067_abnormal_sensory_capabilities | 0.75263727 |
| 115 | MP0002638_abnormal_pupillary_reflex | 0.74277931 |
| 116 | MP0002133_abnormal_respiratory_system | 0.73029005 |
| 117 | MP0005388_respiratory_system_phenotype | 0.73029005 |
| 118 | MP0001299_abnormal_eye_distance/ | 0.72126630 |
| 119 | MP0004145_abnormal_muscle_electrophysio | 0.71854676 |
| 120 | MP0000372_irregular_coat_pigmentation | 0.70760105 |
| 121 | MP0000767_abnormal_smooth_muscle | 0.70686171 |
| 122 | MP0002837_dystrophic_cardiac_calcinosis | 0.70501629 |
| 123 | MP0001533_abnormal_skeleton_physiology | 0.70032516 |
| 124 | MP0004924_abnormal_behavior | 0.69542339 |
| 125 | MP0005386_behavior/neurological_phenoty | 0.69542339 |
| 126 | MP0001784_abnormal_fluid_regulation | 0.68532447 |
| 127 | MP0004484_altered_response_of | 0.68335642 |
| 128 | MP0003279_aneurysm | 0.67946076 |
| 129 | MP0009115_abnormal_fat_cell | 0.67432990 |
| 130 | MP0005076_abnormal_cell_differentiation | 0.66996630 |
| 131 | MP0005310_abnormal_salivary_gland | 0.65935372 |
| 132 | MP0002925_abnormal_cardiovascular_devel | 0.65461844 |
| 133 | MP0006276_abnormal_autonomic_nervous | 0.65288079 |
| 134 | MP0000733_abnormal_muscle_development | 0.63731255 |
| 135 | MP0008569_lethality_at_weaning | 0.63525579 |
| 136 | MP0010352_gastrointestinal_tract_polyps | 0.63107925 |
| 137 | MP0005266_abnormal_metabolism | 0.63046396 |
| 138 | MP0009764_decreased_sensitivity_to | 0.61841868 |
| 139 | MP0005253_abnormal_eye_physiology | 0.59938660 |
| 140 | MP0001919_abnormal_reproductive_system | 0.59634559 |
| 141 | MP0003631_nervous_system_phenotype | 0.58027728 |
| 142 | MP0002971_abnormal_brown_adipose | 0.57253800 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the right ventricle (HP:0001707) | 4.25800533 |
| 2 | Decreased circulating renin level (HP:0003351) | 4.14323984 |
| 3 | Prostate neoplasm (HP:0100787) | 4.04499091 |
| 4 | Abnormality of the fingertips (HP:0001211) | 3.88136060 |
| 5 | Thyroiditis (HP:0100646) | 3.50990324 |
| 6 | T lymphocytopenia (HP:0005403) | 3.32829454 |
| 7 | Subaortic stenosis (HP:0001682) | 3.18603863 |
| 8 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.18603863 |
| 9 | Abnormality of T cell number (HP:0011839) | 3.17505543 |
| 10 | Hypoplastic labia majora (HP:0000059) | 3.13597927 |
| 11 | Hyperventilation (HP:0002883) | 3.11578988 |
| 12 | Abnormal hair whorl (HP:0010721) | 3.06929311 |
| 13 | Hypoplasia of the thymus (HP:0000778) | 3.05015737 |
| 14 | Curly hair (HP:0002212) | 2.94623071 |
| 15 | Genetic anticipation (HP:0003743) | 2.87574783 |
| 16 | Abnormality of B cell number (HP:0010975) | 2.78978028 |
| 17 | B lymphocytopenia (HP:0010976) | 2.78978028 |
| 18 | Abnormality of the prostate (HP:0008775) | 2.78426973 |
| 19 | Cystic hygroma (HP:0000476) | 2.78339104 |
| 20 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.73769618 |
| 21 | Abnormality of the labia majora (HP:0012881) | 2.73489652 |
| 22 | Thyroid carcinoma (HP:0002890) | 2.73487307 |
| 23 | Severe combined immunodeficiency (HP:0004430) | 2.72122615 |
| 24 | Recurrent fungal infections (HP:0002841) | 2.71961179 |
| 25 | Volvulus (HP:0002580) | 2.66326029 |
| 26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.62050671 |
| 27 | Gingival bleeding (HP:0000225) | 2.58685787 |
| 28 | Recurrent viral infections (HP:0004429) | 2.57843716 |
| 29 | Myositis (HP:0100614) | 2.55673770 |
| 30 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.55582350 |
| 31 | Narrow palate (HP:0000189) | 2.51771667 |
| 32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.50122617 |
| 33 | Truncal obesity (HP:0001956) | 2.47756946 |
| 34 | Lip pit (HP:0100267) | 2.46010015 |
| 35 | Panhypogammaglobulinemia (HP:0003139) | 2.40567697 |
| 36 | Peritonitis (HP:0002586) | 2.38287610 |
| 37 | Chronic diarrhea (HP:0002028) | 2.38203925 |
| 38 | Impaired proprioception (HP:0010831) | 2.38187708 |
| 39 | Smooth philtrum (HP:0000319) | 2.34680580 |
| 40 | Optic neuritis (HP:0100653) | 2.33851376 |
| 41 | Retrobulbar optic neuritis (HP:0100654) | 2.33851376 |
| 42 | Absent speech (HP:0001344) | 2.33691878 |
| 43 | Recurrent abscess formation (HP:0002722) | 2.33638065 |
| 44 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.31467822 |
| 45 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.31467822 |
| 46 | Deep philtrum (HP:0002002) | 2.31114252 |
| 47 | Febrile seizures (HP:0002373) | 2.29403840 |
| 48 | Absent frontal sinuses (HP:0002688) | 2.29040543 |
| 49 | Eczematoid dermatitis (HP:0000976) | 2.27656514 |
| 50 | Spontaneous hematomas (HP:0007420) | 2.27542225 |
| 51 | Chronic otitis media (HP:0000389) | 2.24933647 |
| 52 | Recurrent cutaneous fungal infections (HP:0011370) | 2.23665840 |
| 53 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.23665840 |
| 54 | Overgrowth (HP:0001548) | 2.21407201 |
| 55 | Increased density of long bones (HP:0006392) | 2.18991283 |
| 56 | Acute myeloid leukemia (HP:0004808) | 2.18984239 |
| 57 | Patent foramen ovale (HP:0001655) | 2.18010945 |
| 58 | Subacute progressive viral hepatitis (HP:0006572) | 2.17505100 |
| 59 | Increased number of teeth (HP:0011069) | 2.17375933 |
| 60 | Eosinophilia (HP:0001880) | 2.16395377 |
| 61 | Abnormality of incisor morphology (HP:0011063) | 2.14962801 |
| 62 | Macroorchidism (HP:0000053) | 2.13532329 |
| 63 | Short chin (HP:0000331) | 2.13393546 |
| 64 | Chest pain (HP:0100749) | 2.12933999 |
| 65 | Heterotopia (HP:0002282) | 2.11147041 |
| 66 | Generalized hypopigmentation of hair (HP:0011358) | 2.10556943 |
| 67 | Abnormality of the renal cortex (HP:0011035) | 2.09527315 |
| 68 | Mediastinal lymphadenopathy (HP:0100721) | 2.08978544 |
| 69 | Alveolar cell carcinoma (HP:0006519) | 2.07852392 |
| 70 | Abnormality of T cells (HP:0002843) | 2.07700792 |
| 71 | Menstrual irregularities (HP:0000858) | 2.07698907 |
| 72 | Frequent falls (HP:0002359) | 2.07258883 |
| 73 | Submucous cleft hard palate (HP:0000176) | 2.06742707 |
| 74 | Arterial thrombosis (HP:0004420) | 2.02179882 |
| 75 | Progressive cerebellar ataxia (HP:0002073) | 2.00967862 |
| 76 | Stomach cancer (HP:0012126) | 2.00861418 |
| 77 | Recurrent bronchitis (HP:0002837) | 2.00033479 |
| 78 | Spinal cord lesions (HP:0100561) | 1.99963776 |
| 79 | Syringomyelia (HP:0003396) | 1.99963776 |
| 80 | Abnormality of the nasal septum (HP:0000419) | 1.96955425 |
| 81 | Orchitis (HP:0100796) | 1.95791694 |
| 82 | Symptomatic seizures (HP:0011145) | 1.93704475 |
| 83 | IgG deficiency (HP:0004315) | 1.93460398 |
| 84 | IgA deficiency (HP:0002720) | 1.93101374 |
| 85 | Aortic regurgitation (HP:0001659) | 1.92830496 |
| 86 | Protruding tongue (HP:0010808) | 1.92698402 |
| 87 | Meningitis (HP:0001287) | 1.92072944 |
| 88 | Tubulointerstitial nephritis (HP:0001970) | 1.91766939 |
| 89 | Progressive sensorineural hearing impairment (HP:0000408) | 1.91760479 |
| 90 | Prominent nose (HP:0000448) | 1.90888915 |
| 91 | Gaze-evoked nystagmus (HP:0000640) | 1.90619256 |
| 92 | Ureteral obstruction (HP:0006000) | 1.90064354 |
| 93 | Facial diplegia (HP:0001349) | 1.89689910 |
| 94 | Hematochezia (HP:0002573) | 1.89427480 |
| 95 | Stomatitis (HP:0010280) | 1.88698803 |
| 96 | Hypoglycemic seizures (HP:0002173) | 1.87575046 |
| 97 | Keratoconjunctivitis sicca (HP:0001097) | 1.86997817 |
| 98 | Wide nose (HP:0000445) | 1.86919003 |
| 99 | Increased mean platelet volume (HP:0011877) | 1.86770751 |
| 100 | Abnormal platelet volume (HP:0011876) | 1.86639025 |
| 101 | Abnormality of the metopic suture (HP:0005556) | 1.85811859 |
| 102 | Postural instability (HP:0002172) | 1.85599679 |
| 103 | Drooling (HP:0002307) | 1.85261178 |
| 104 | Widely spaced teeth (HP:0000687) | 1.85142722 |
| 105 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.85069372 |
| 106 | IgM deficiency (HP:0002850) | 1.85021010 |
| 107 | Abnormality of eosinophils (HP:0001879) | 1.84135471 |
| 108 | Pulmonary infiltrates (HP:0002113) | 1.83980090 |
| 109 | Combined immunodeficiency (HP:0005387) | 1.83897715 |
| 110 | Abnormality of the corticospinal tract (HP:0002492) | 1.82399140 |
| 111 | Recurrent bacterial skin infections (HP:0005406) | 1.82360369 |
| 112 | Pancreatic cysts (HP:0001737) | 1.82158112 |
| 113 | Excessive salivation (HP:0003781) | 1.81805282 |
| 114 | Long clavicles (HP:0000890) | 1.81636619 |
| 115 | Hypochromic microcytic anemia (HP:0004840) | 1.81392717 |
| 116 | Periodontitis (HP:0000704) | 1.80265452 |
| 117 | Papillary thyroid carcinoma (HP:0002895) | 1.80086424 |
| 118 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.80085358 |
| 119 | Prolonged bleeding time (HP:0003010) | 1.79975266 |
| 120 | Long eyelashes (HP:0000527) | 1.79264096 |
| 121 | Blue irides (HP:0000635) | 1.78623661 |
| 122 | Autoimmune hemolytic anemia (HP:0001890) | 1.78279534 |
| 123 | Fair hair (HP:0002286) | 1.76279996 |
| 124 | Sandal gap (HP:0001852) | 1.76274057 |
| 125 | Epistaxis (HP:0000421) | 1.75817918 |
| 126 | Inflammation of the large intestine (HP:0002037) | 1.75414105 |
| 127 | Hip dysplasia (HP:0001385) | 1.75351448 |
| 128 | Gastrointestinal infarctions (HP:0005244) | 1.75170292 |
| 129 | Tapered finger (HP:0001182) | 1.74934852 |
| 130 | Gingivitis (HP:0000230) | 1.74902742 |
| 131 | Keratoconjunctivitis (HP:0001096) | 1.74823306 |
| 132 | Coarse hair (HP:0002208) | 1.74686376 |
| 133 | Leukocytosis (HP:0001974) | 1.74075660 |
| 134 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.73839396 |
| 135 | Exostoses (HP:0100777) | 1.73585616 |
| 136 | Granulocytopenia (HP:0001913) | 1.73314494 |
| 137 | Birth length less than 3rd percentile (HP:0003561) | 1.73253986 |
| 138 | Spondylolisthesis (HP:0003302) | 1.71841305 |
| 139 | Hemoptysis (HP:0002105) | 1.71799463 |
| 140 | Renal cortical cysts (HP:0000803) | 1.71730648 |
| 141 | Vasculitis (HP:0002633) | 1.71573406 |
| 142 | Ureteral stenosis (HP:0000071) | 1.70539872 |
| 143 | Viral hepatitis (HP:0006562) | 1.69514549 |
| 144 | Low anterior hairline (HP:0000294) | 1.68703394 |
| 145 | Oligodactyly (hands) (HP:0001180) | 1.68392713 |
| 146 | Neoplasm of the adrenal cortex (HP:0100641) | 1.68322491 |
| 147 | Abnormality of the ischium (HP:0003174) | 1.67804237 |
| 148 | Hypoplasia of the maxilla (HP:0000327) | 1.67440626 |
| 149 | Lower limb muscle weakness (HP:0007340) | 1.66041347 |
| 150 | Cubitus valgus (HP:0002967) | 1.60837315 |
| 151 | Hypoplastic nipples (HP:0002557) | 1.60754193 |
| 152 | Difficulty running (HP:0009046) | 1.60064434 |
| 153 | Short foot (HP:0001773) | 1.59911909 |
| 154 | Broad ribs (HP:0000885) | 1.59900304 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 3.91508237 |
| 2 | AKT3 | 3.32218158 |
| 3 | TXK | 2.94249934 |
| 4 | IRAK4 | 2.69524367 |
| 5 | MAP4K1 | 2.34227212 |
| 6 | TNIK | 2.11790556 |
| 7 | FRK | 2.08289241 |
| 8 | JAK3 | 2.07100665 |
| 9 | MAP3K14 | 2.05931639 |
| 10 | BMPR1B | 2.03969905 |
| 11 | PIK3CG | 1.93511533 |
| 12 | FGFR3 | 1.91069072 |
| 13 | ITK | 1.76350339 |
| 14 | TAOK3 | 1.72137553 |
| 15 | BRSK2 | 1.70383666 |
| 16 | ACVR1B | 1.64878849 |
| 17 | MAP3K4 | 1.64338670 |
| 18 | IKBKE | 1.63572456 |
| 19 | JAK1 | 1.61037839 |
| 20 | PRKCH | 1.60272318 |
| 21 | NUAK1 | 1.59465918 |
| 22 | CAMK1G | 1.55213413 |
| 23 | MAP3K2 | 1.55113172 |
| 24 | TEC | 1.49229905 |
| 25 | FGFR2 | 1.48235230 |
| 26 | SGK2 | 1.42558421 |
| 27 | CSK | 1.40485871 |
| 28 | TTN | 1.37623260 |
| 29 | SIK2 | 1.36469173 |
| 30 | PINK1 | 1.35273565 |
| 31 | TNK2 | 1.33537972 |
| 32 | KSR1 | 1.33063093 |
| 33 | IRAK3 | 1.32499965 |
| 34 | MUSK | 1.32243728 |
| 35 | FES | 1.31192822 |
| 36 | NLK | 1.30980607 |
| 37 | YES1 | 1.30407311 |
| 38 | TRPM7 | 1.29731831 |
| 39 | BMPR2 | 1.29175267 |
| 40 | SGK3 | 1.28785710 |
| 41 | ZAP70 | 1.28698683 |
| 42 | HIPK2 | 1.28499597 |
| 43 | MAP2K4 | 1.28322565 |
| 44 | MAP3K6 | 1.27972763 |
| 45 | PTK6 | 1.27331988 |
| 46 | TYK2 | 1.26301457 |
| 47 | CDK12 | 1.25018716 |
| 48 | LATS1 | 1.24282697 |
| 49 | TGFBR2 | 1.19613449 |
| 50 | BTK | 1.17431586 |
| 51 | PASK | 1.15955502 |
| 52 | PAK3 | 1.12821225 |
| 53 | CHUK | 1.12360450 |
| 54 | ERBB3 | 1.08811888 |
| 55 | IRAK1 | 1.06243485 |
| 56 | BLK | 1.04781968 |
| 57 | KIT | 1.04474705 |
| 58 | LCK | 1.04326168 |
| 59 | PRKCQ | 1.04107889 |
| 60 | STK38L | 0.99401844 |
| 61 | PDGFRB | 0.99219214 |
| 62 | ZAK | 0.97265314 |
| 63 | FGFR4 | 0.97244158 |
| 64 | HCK | 0.96980552 |
| 65 | RIPK4 | 0.96183340 |
| 66 | EIF2AK3 | 0.94151680 |
| 67 | SYK | 0.93696255 |
| 68 | CAMKK2 | 0.93225908 |
| 69 | CAMK1D | 0.92071662 |
| 70 | PRKD2 | 0.91493178 |
| 71 | TBK1 | 0.91138250 |
| 72 | CASK | 0.89876229 |
| 73 | PNCK | 0.88852261 |
| 74 | MAP2K7 | 0.88770032 |
| 75 | MKNK2 | 0.87424683 |
| 76 | NEK9 | 0.84483357 |
| 77 | PIK3CA | 0.83924007 |
| 78 | SIK3 | 0.81532938 |
| 79 | BRD4 | 0.80560222 |
| 80 | STK3 | 0.77180071 |
| 81 | PLK2 | 0.74415264 |
| 82 | IRAK2 | 0.74008637 |
| 83 | PTK2B | 0.73842433 |
| 84 | CSNK1A1L | 0.73746901 |
| 85 | STK11 | 0.72694191 |
| 86 | PDGFRA | 0.71674371 |
| 87 | DMPK | 0.71646963 |
| 88 | OBSCN | 0.71346335 |
| 89 | MAP3K7 | 0.69521278 |
| 90 | JAK2 | 0.68922725 |
| 91 | WNK1 | 0.66520055 |
| 92 | STK24 | 0.66442551 |
| 93 | IKBKB | 0.65063768 |
| 94 | LYN | 0.63266632 |
| 95 | MKNK1 | 0.62610353 |
| 96 | CAMKK1 | 0.62106824 |
| 97 | WNK3 | 0.60988206 |
| 98 | EPHA3 | 0.59120888 |
| 99 | STK10 | 0.58754972 |
| 100 | BCR | 0.58111115 |
| 101 | RAF1 | 0.57980845 |
| 102 | MAP2K3 | 0.57821956 |
| 103 | RET | 0.57110302 |
| 104 | SGK1 | 0.56810403 |
| 105 | CDK6 | 0.56295278 |
| 106 | IGF1R | 0.56271537 |
| 107 | ERBB2 | 0.55305691 |
| 108 | SGK494 | 0.54896477 |
| 109 | SGK223 | 0.54896477 |
| 110 | ADRBK1 | 0.54710006 |
| 111 | GRK6 | 0.54328653 |
| 112 | RPS6KB1 | 0.54251643 |
| 113 | MARK3 | 0.54179469 |
| 114 | CAMK4 | 0.52796400 |
| 115 | RPS6KA2 | 0.52687182 |
| 116 | STK39 | 0.51529365 |
| 117 | TIE1 | 0.51036150 |
| 118 | PIM1 | 0.50903807 |
| 119 | DYRK3 | 0.50707788 |
| 120 | ABL1 | 0.48437692 |
| 121 | DYRK1A | 0.47760078 |
| 122 | MAP3K13 | 0.47696603 |
| 123 | CDK3 | 0.47551960 |
| 124 | RIPK1 | 0.46483876 |
| 125 | ADRBK2 | 0.46044139 |
| 126 | MARK1 | 0.45607129 |
| 127 | CSF1R | 0.45319151 |
| 128 | SCYL2 | 0.45182376 |
| 129 | PRKAA2 | 0.45068845 |
| 130 | PKN2 | 0.44160664 |
| 131 | MAPK13 | 0.44069961 |
| 132 | FGR | 0.44050231 |
| 133 | NTRK3 | 0.43817395 |
| 134 | CAMK1 | 0.43215650 |
| 135 | EPHB1 | 0.43080651 |
| 136 | MAP3K5 | 0.42659537 |
| 137 | STK4 | 0.42607544 |
| 138 | MARK2 | 0.42117563 |
| 139 | TAF1 | 0.40889268 |
| 140 | FLT3 | 0.40356875 |
| 141 | PRKCE | 0.40180523 |
| 142 | PRKD1 | 0.38669953 |
| 143 | INSR | 0.38154673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.45387152 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.97639763 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.89243529 |
| 4 | Measles_Homo sapiens_hsa05162 | 1.77161395 |
| 5 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.70414233 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.68972077 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.64150962 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.63080256 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.61773130 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.60917823 |
| 11 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.59696374 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.57768333 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.40323065 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.37995778 |
| 15 | Platelet activation_Homo sapiens_hsa04611 | 1.32845846 |
| 16 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.29603107 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.28041454 |
| 18 | Lysine degradation_Homo sapiens_hsa00310 | 1.26872801 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26456139 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.25635935 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.25122551 |
| 22 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.23330814 |
| 23 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23005862 |
| 24 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.22512064 |
| 25 | Insulin secretion_Homo sapiens_hsa04911 | 1.21585506 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.18964075 |
| 27 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.16050221 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14931909 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14767196 |
| 30 | Glioma_Homo sapiens_hsa05214 | 1.14242140 |
| 31 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.14175977 |
| 32 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.11621080 |
| 33 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.09014864 |
| 34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.08588431 |
| 35 | Allograft rejection_Homo sapiens_hsa05330 | 1.07497314 |
| 36 | Renin secretion_Homo sapiens_hsa04924 | 1.07017559 |
| 37 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.01878962 |
| 38 | Insulin resistance_Homo sapiens_hsa04931 | 0.99984157 |
| 39 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.99141033 |
| 40 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.99122739 |
| 41 | Prostate cancer_Homo sapiens_hsa05215 | 0.98910724 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.98797551 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96802870 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.96233615 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95185297 |
| 46 | Adherens junction_Homo sapiens_hsa04520 | 0.93715129 |
| 47 | Tuberculosis_Homo sapiens_hsa05152 | 0.93673852 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.93586418 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92924121 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 0.91803095 |
| 51 | Influenza A_Homo sapiens_hsa05164 | 0.90786011 |
| 52 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.90555167 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.90196001 |
| 54 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.89883671 |
| 55 | Focal adhesion_Homo sapiens_hsa04510 | 0.89218561 |
| 56 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.88504651 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.88170564 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86838979 |
| 59 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.86784362 |
| 60 | Endometrial cancer_Homo sapiens_hsa05213 | 0.86641239 |
| 61 | Circadian entrainment_Homo sapiens_hsa04713 | 0.86621181 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86600341 |
| 63 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.85562784 |
| 64 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.85333680 |
| 65 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.84510474 |
| 66 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.84300252 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.83166911 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.82540101 |
| 69 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.82093376 |
| 70 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.82091010 |
| 71 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.81718431 |
| 72 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.81248209 |
| 73 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.80435021 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.78432978 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78308902 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77964421 |
| 77 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.77782894 |
| 78 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.77459928 |
| 79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.77422809 |
| 80 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.77421406 |
| 81 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.77330899 |
| 82 | Gap junction_Homo sapiens_hsa04540 | 0.77019212 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76872925 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76458951 |
| 85 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.75985285 |
| 86 | Long-term potentiation_Homo sapiens_hsa04720 | 0.75939859 |
| 87 | Melanoma_Homo sapiens_hsa05218 | 0.74425867 |
| 88 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.74261807 |
| 89 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.74104696 |
| 90 | Axon guidance_Homo sapiens_hsa04360 | 0.72194076 |
| 91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71126868 |
| 92 | HTLV-I infection_Homo sapiens_hsa05166 | 0.70465344 |
| 93 | Colorectal cancer_Homo sapiens_hsa05210 | 0.70237303 |
| 94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69462932 |
| 95 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.69388801 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68647565 |
| 97 | Malaria_Homo sapiens_hsa05144 | 0.67624283 |
| 98 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.67509622 |
| 99 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.67030843 |
| 100 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.65870789 |
| 101 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65854344 |
| 102 | Legionellosis_Homo sapiens_hsa05134 | 0.65815275 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65433005 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65385338 |
| 105 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65213962 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64908062 |
| 107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64574074 |
| 108 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64457889 |
| 109 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64185690 |
| 110 | Pertussis_Homo sapiens_hsa05133 | 0.62559677 |
| 111 | Pathways in cancer_Homo sapiens_hsa05200 | 0.62408210 |
| 112 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.62318376 |
| 113 | Morphine addiction_Homo sapiens_hsa05032 | 0.62282182 |
| 114 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.62054250 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | 0.61717260 |
| 116 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61591143 |
| 117 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60953695 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60553605 |
| 119 | Alcoholism_Homo sapiens_hsa05034 | 0.60514554 |
| 120 | Circadian rhythm_Homo sapiens_hsa04710 | 0.60349444 |
| 121 | Olfactory transduction_Homo sapiens_hsa04740 | 0.59969083 |
| 122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59290952 |
| 123 | Salmonella infection_Homo sapiens_hsa05132 | 0.57778550 |
| 124 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57190234 |
| 125 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.56924222 |
| 126 | Taste transduction_Homo sapiens_hsa04742 | 0.56191750 |

